MELISSA MCKEY: Open Payments
NPI 1699198754 · NEDERLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$728 in 51 payments from 11 companies in 2025. Trend: 2023 $15 · 2024 $291 · 2025 $728
Food & beverage: $728
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $290 |
| Novo Nordisk Inc | 9 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
| Axsome Therapeutics, Inc. | 3 | $50 |
| PFIZER INC. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Corcept Therapeutics | 1 | $18 |
| TOLMAR, INC. | 1 | $14 |
Products named: VRAYLAR, QULIPTA, TRINTELLIX, Wegovy, UBRELVY, CAPLYTA, Auvelity, Rybelsus.
Industry payments across TX — which companies pay providers there.
